• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Why GlaxoSmithKline Stock Jumped 25% on Thursday

cafead

Administrator
Staff member
  • cafead   Jul 21, 2022 at 10:02: PM
via
  • GSK said it expects yearly revenue to increase as much as 14% in 2022.
  • The company just completed the spin-off of its consumer healthcare division earlier this week.
  • GSK is scheduled to release second-quarter numbers next week.

article source
 

<